Evidence map›Paper›PMID 30625987›Full record

ArticleInternational journal of molecular sciences2019

HPV-Mediated Resistance to TNF and TRAIL Is Characterized by Global Alterations in Apoptosis Regulatory Factors, Dysregulation of Death Receptors, and Induction of ROS/RNS.

Tatiane Karen Cabeça, Alice de Mello Abreu, Rafael Andrette, Vanesca de Souza Lino, Mirian Galliote Morale, Francisco Aguayo, Lara Termini, Luisa Lina Villa, Ana Paula Lepique, Enrique Boccardo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Complement component 3c and tumor necrosis factor-α systemic assessment after Candida antigen immunotherapy in cutaneous warts.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2020
    Trial
  2. Article
  3. Article
  4. Viral oncogenesis in cancer: from mechanisms to therapeutics.Signal transduction and targeted therapy · 2025
    Review
  5. Review
  6. Review
  7. Do or Die: HPV E5, E6 and E7 in Cell Death Evasion.Pathogens (Basel, Switzerland) · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Tatiane Karen CabeçaDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, 05508-900 São Paulo, Brazil. taticabeca@yahoo.com.br.
Alice de Mello AbreuDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, 05508-900 São Paulo, Brazil. liabreu@yahoo.com.br.
Rafael AndretteDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, 05508-900 São Paulo, Brazil. rafaelandrette@outlook.com.
Vanesca de Souza LinoDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, 05508-900 São Paulo, Brazil. vanesca_lino@hotmail.com.
Mirian Galliote MoraleLaboratório de Inovação em Câncer, Centro de Investigação Translacional em Oncologia (LIM24), Instituto do Câncer do Estado de São Paulo (ICESP), 01246-000 São Paulo, Brazil. mirian.galliote@gmail.com.ORCID 0000-0002-2778-7697
Francisco AguayoDepartment of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, 8389100 Santiago, Chile. faguayo@med.uchile.cl.ORCID 0000-0002-9619-7535
Lara TerminiLaboratório de Inovação em Câncer, Centro de Investigação Translacional em Oncologia (LIM24), Instituto do Câncer do Estado de São Paulo (ICESP), 01246-000 São Paulo, Brazil. terminilara@gmail.com.
Luisa Lina VillaLaboratório de Inovação em Câncer, Centro de Investigação Translacional em Oncologia (LIM24), Instituto do Câncer do Estado de São Paulo (ICESP), 01246-000 São Paulo, Brazil. luisapvilla@gmail.com.
Ana Paula LepiqueDepartment of Immunology, Institute of Biomedical Sciences, University of São Paulo, 05508-900 São Paulo, Brazil. alepique@icb.usp.br.ORCID 0000-0002-4707-2912
Enrique BoccardoDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, 05508-900 São Paulo, Brazil. eboccardo@usp.br.ORCID 0000-0003-1900-0273
Universidade de São Paulo · BRInstituto do Câncer do Estado de São Paulo · BRAdvanced Center for Chronic Diseases · CL

Funding

DISEASE PREVENTION ANALYSIS OF INTESTINAL METAPLASIAF06TW002008 · FIC · UNIVERSITY OF ARIZONA · PI AICKIN, MIKEL G · 1994 to 1994
–
Conselho Nacional de Desenvolvimento Científico e Tecnológico 573799/2008-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2008/03232-1; 2010/20002-0; 2008/57889-1; 2011/14416-9
6 · The paper itself

Abstract

Persistent infection with high-risk human papilloma virus (HR-HPV) is the main risk factor for the development of invasive cervical cancer although is not sufficient to cause cervical cancer. Several host and environmental factors play a key role in cancer initiation/progression, including cytokines and other immune-response mediators. Here, we characterized the response to the individual and combined action of the pro-inflammatory cytokines tumor necrosis factor (TNF) and TNF-related apoptosis-inducing ligand (TRAIL) on HPV-transformed cells and human keratinocytes ectopically expressing E6 and E7 early proteins from different HPV types. We showed that keratinocytes expressing HPV early proteins exhibited global alterations in the expression of proteins involved in apoptosis regulation/execution, including TNF and TRAIL receptors. Besides, we provided evidence that TNF receptor 1 (TNFR1) was down-regulated and may be retained in the cytoplasm of keratinocytes expressing HPV16 oncoproteins. Finally, fluorescence analysis demonstrated that cytokine treatment induced the production and release of reactive oxygen and nitrogen species (ROS/RNS) in cells expressing HPV oncogenes. Alterations in ROS/RNS production and apoptosis regulatory factors expression in response to inflammatory mediators may favor the accumulation of genetic alterations in HPV-infected cells. Altogether, our results suggested that these events may contribute to lesion progression and cancer onset.

Indexed as

Apoptosis Regulatory ProteinsDown-RegulationDrug Resistance, NeoplasmHeLa CellsHumansInflammation MediatorsKeratinocytesMembrane Potential, MitochondrialNF-kappa BOncogenesPapillomaviridaeReactive Nitrogen SpeciesReactive Oxygen SpeciesReceptors, Death DomainReceptors, Tumor Necrosis Factor, Type ISignal TransductionApoptosis Regulatory ProteinsInflammation MediatorsNF-kappa BReactive Nitrogen SpeciesReactive Oxygen SpeciesReceptors, Death DomainReceptors, Tumor Necrosis Factor, Type ITNF-Related Apoptosis-Inducing LigandTumor Necrosis Factor-alphaViral ProteinsapoptosisHPVROS/RNSTNFTRAIL

Identifiers

PMID30625987
PMCPMC6337392
OpenAlexW2906944698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.